ES519559A0 - Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas. - Google Patents

Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.

Info

Publication number
ES519559A0
ES519559A0 ES519559A ES519559A ES519559A0 ES 519559 A0 ES519559 A0 ES 519559A0 ES 519559 A ES519559 A ES 519559A ES 519559 A ES519559 A ES 519559A ES 519559 A0 ES519559 A0 ES 519559A0
Authority
ES
Spain
Prior art keywords
pirazolotiacinas
pirazoloquinolinas
pirazolooxacinas
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519559A
Other languages
English (en)
Other versions
ES8402591A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8402591A1 publication Critical patent/ES8402591A1/es
Publication of ES519559A0 publication Critical patent/ES519559A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES519559A 1982-02-06 1983-02-04 Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas. Granted ES519559A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8402591A1 ES8402591A1 (es) 1984-02-01
ES519559A0 true ES519559A0 (es) 1984-02-01

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519559A Granted ES519559A0 (es) 1982-02-06 1983-02-04 Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.

Country Status (16)

Country Link
US (1) US4552874A (es)
EP (1) EP0085881A3 (es)
JP (1) JPS58146583A (es)
KR (1) KR840003641A (es)
AU (1) AU1112583A (es)
DE (1) DE3204126A1 (es)
DK (1) DK49283A (es)
ES (1) ES519559A0 (es)
FI (1) FI830378A7 (es)
GR (1) GR77960B (es)
HU (1) HU190063B (es)
IE (1) IE830227L (es)
IL (1) IL67826A0 (es)
NO (1) NO830236L (es)
PT (1) PT76147A (es)
ZA (1) ZA83743B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
ES8602818A1 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
EP0913395A1 (en) * 1995-12-08 1999-05-06 Ube Industries, Ltd. N-phenylcarbamate compounds, process for producing the same, and agricultural or horticultural bactericides
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Ｃｄ５＋ｂ細胞リンパ腫の治療方法
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1673087B1 (en) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US7863266B2 (en) * 2007-06-08 2011-01-04 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
ATE544344T1 (de) * 2007-06-08 2012-02-15 Helicon Therapeutics Inc Therapeutische pyrazolochinolinderivate
ES2483728T3 (es) * 2007-06-08 2014-08-07 Dart Neuroscience (Cayman) Ltd Derivados terapéuticos de pirazolonafatiridina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
NO830236L (no) 1983-08-08
DK49283D0 (da) 1983-02-04
IL67826A0 (en) 1983-06-15
EP0085881A2 (de) 1983-08-17
EP0085881A3 (de) 1984-03-07
AU1112583A (en) 1983-08-11
ZA83743B (en) 1983-11-30
FI830378L (fi) 1983-08-07
FI830378A0 (fi) 1983-02-03
JPS58146583A (ja) 1983-09-01
ES8402591A1 (es) 1984-02-01
DE3204126A1 (de) 1983-08-11
US4552874A (en) 1985-11-12
FI830378A7 (fi) 1983-08-07
PT76147A (en) 1983-02-01
KR840003641A (ko) 1984-09-15
HU190063B (en) 1986-08-28
IE830227L (en) 1983-08-06
GR77960B (es) 1984-09-25
DK49283A (da) 1983-08-07

Similar Documents

Publication Publication Date Title
ES528628A0 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES516368A0 (es) Procedimiento para la obtencion de fenoxifenil-azol-metilcetonas y-carbinoles.
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES507307A0 (es) Procedimiento para la determinacion de colesterina.
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES520812A0 (es) Procedimiento para la preparacion de 3-azolil-1,2-diaril-1-halogeno-1-propenos.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
ES523497A0 (es) Procedimiento para preparar n-fosfonometilglicina.
ES510596A0 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES520599A0 (es) Procedimiento para la obtencion de fenoxipropiltriazolil-cetonas y carbinoles.
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
AR240317A1 (es) Procedimiento para la preparacion de pirimidinatrionas n-monosubtituidas-5,5-disubtituidas.
ES521979A0 (es) Procedimiento para la preparacion de disulfuros.
ES523990A0 (es) Procedimiento para la preparacion de furobenzoisoxazoles.
ES521331A0 (es) Procedimiento para la preparacion de n-pteridinilureas.
ES520847A0 (es) Procedimiento para la preparacion de 1,2,4-triazol-1-il-propionitrilos.
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES520201A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
ES512786A0 (es) Procedimiento para la obtencion de o-alquiluretanos n-monosustituidos.
ES522967A0 (es) Procedimiento para la obtencion de alquilen(cicloalquilen)-bis-heterociclil-biguanidas.
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009